ACE2 and Alzheimer disease: To probe whether changes in ACE2 could be a consequence of classical tau and Aβ neuropathology, we used the triple transgenic mouse model of AD (3xTg-AD) [64], which develops Aβ plaques and neurofibrillary tangles (NFT) by 12 months of age.